Everolimus-based immunosuppression in patients with hepatocellular carcinoma at high risk of recurrence after liver transplantation: a case series.
Ferreiro, A O
Everolimus-based immunosuppression in patients with hepatocellular carcinoma at high risk of recurrence after liver transplantation: a case series. [electronic resource] - Transplantation proceedings Dec 2014 - 3496-501 p. digital
Publication Type: Journal Article
1873-2623
10.1016/j.transproceed.2014.08.045 doi
Antineoplastic Agents
Carcinoma, Hepatocellular--drug therapy
Everolimus
Female
Humans
Immunosuppression Therapy--methods
Immunosuppressive Agents--therapeutic use
Liver Neoplasms--drug therapy
Liver Transplantation
Male
Middle Aged
Neoplasm Recurrence, Local--prevention & control
Sirolimus--analogs & derivatives
Treatment Outcome
Everolimus-based immunosuppression in patients with hepatocellular carcinoma at high risk of recurrence after liver transplantation: a case series. [electronic resource] - Transplantation proceedings Dec 2014 - 3496-501 p. digital
Publication Type: Journal Article
1873-2623
10.1016/j.transproceed.2014.08.045 doi
Antineoplastic Agents
Carcinoma, Hepatocellular--drug therapy
Everolimus
Female
Humans
Immunosuppression Therapy--methods
Immunosuppressive Agents--therapeutic use
Liver Neoplasms--drug therapy
Liver Transplantation
Male
Middle Aged
Neoplasm Recurrence, Local--prevention & control
Sirolimus--analogs & derivatives
Treatment Outcome